Skip to main content

Table 3 MBFi ( K 1 ), MVO 2 ( k 2 ), and RPP responses to NE- and SB-stress

From: β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using 11C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism

Group

Stressor dose (μg/kg/min)

MBFi ratio (stress/rest)

MVO2ratio (stress/rest)

OEFi ratio (stress/rest)

RPP ratio (stress/rest)

sMFR (RPP-adjusted)

Normal

NE 3.2

1.68 ± 0.42

1.58 ± 0.28

0.99 ± 0.29

1.19 ± 0.10

1.39 ± 0.35 (25%)

 

SB 0.2

1.39 ± 0.27

1.37 ± 0.15

1.00 ± 0.10

1.00 ± 0.02*

1.39 ± 0.27 (19%)

 

SB 1.0

1.75 ± 0.25***

1.73 ± 0.23***

1.00 ± 0.14

0.98 ± 0.02*

1.78 ± 0.25*** (14%)

 

PHE + NE 3.2

1.61 ± 0.51

1.95 ± 0.45

1.27 ± 0.35

0.89 ± 0.15*

1.81 ± 0.57 (32%)

eNOS knockout

NE 3.2

1.12 ± 0.23*

1.57 ± 0.34

1.46 ± 0.50

1.13 ± 0.04

0.99 ± 0.20* (20%)

NOS inhibition

NE 3.2

1.03 ± 0.23*

1.35 ± 0.20

1.35 ± 0.29

1.07 ± 0.02*

0.96 ± 0.22* (23%)

 

SB 0.2

0.99 ± 0.15*,**

1.17 ± 0.08*,**

1.20 ± 0.12**

1.00 ± 0.03*

0.98 ± 0.15*,** (15%)

 

SB 1.0

1.38 ± 0.17**,***

1.58 ± 0.37***

1.16 ± 0.29

0.99 ± 0.02*

1.39 ± 0.17**,*** (12%)

  1. MBFi, myocardial blood flow index; MVO2, myocardial oxygen consumption; OEFi = MVO2/MBFi, oxygen extraction fraction index; RPP, heart rate × systolic blood pressure product; eNOS, endothelial nitric oxide synthase; NE, norepinephrine; SB, salbutamol. Sympathetic-stress myocardial flow reserve (sMFR) RPP-adjusted = MBFi ratio/RPP ratio; NOS inhibition = L-NAME pretreated. Nitric-oxide-mediated endothelial flow reserve (EFRNOM) values shown in italics. Values are mean ±standard deviation (coefficient of variation × 100%). *p < 0.05 vs. normal NE. **p < 0.05 vs. normal SB with same dose. ***p < 0.05 vs. low-dose SB (0.2 μg/kg/min).